P3H1 and osteogenesis imperfecta: As prototype defects for a first proof of concept of the efficacy of HSP47 treatment in the presence of collagen with abnormal structure, we chose the recessive OI types VII (OMIM #610682) and VIII (OMIM #610915) caused by mutations in CRTAP and P3H1, respectively (30, 31).